-
1 . Academic Journal
Safety and immunogenicity of a two-dose heterologous Ad26.ZEBOV and MVA-BN-Filo Ebola vaccine regimen in adults in Europe (EBOVAC2): a randomised, observer-blind, participant-blind, placebo-controlled, phase 2 trial
- 저자
- by McShane, Christopher; Callendret, Benoit; Dincq, Stephanie; Ferrault, Camille; Chai, Siew Pin, et al.
- 소스
- In The Lancet Infectious Diseases April 2021 21(4):493-506